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ABSTRACT

Cardiovascular diseases are the leading cause of death in the United States.
Atherosclerosis in peripheral arteries is a major contributing factor. Autologous
saphenous vein grafts are the most common bypass grafts for treating peripheral artery
diseases. A quarter of these grafts fail within a year, and around half have failed within
10 years of the initial surgery. Graft failure is attributed to the development of intimal
hyperplasia indicated by the migration and proliferation of vascular smooth muscle cells,
fibroblasts, and the deposition of extracellular proteins.
Increases in flow, pressure, the pulse frequency, and the differential of pressure
that model an arterial environment have been shown to trigger intimal hyperplasia. These
tend to occur at the sites of flow disruption most often associated with the anastomotic
sites. Turbid blood flow due to flow separation and flow reversal promote positive factors
for intimal hyperplasia.
Perfusion bioreactors have allowed researchers to study vein grafts ex-vivo,
creating a better understanding of vein remodeling. The goal of this project was to
emulate the pressure, flow, and pulse frequency of the peripheral arterial environment.
We developed a lab-built four-channel pulsatile flow perfusion bioreactor, which has the
unique design features for testing varying vascular grafts and grafting techniques using
optical coherence tomography and particle imaging velocimetry.
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CHAPTER ONE
INTRODUCTION AND BACKGROUND

Cardiovascular disease is the current leading cause of death for men and women in
the United States killing 659,000 people on average every year (American Heart
Association 2021). People who suffer from a host of diseases and lifestyle choices such
as diabetes, obesity, addiction to alcohol, addiction to tobacco smoking, and physical
inactivity are all at increased risk of suffering from cardiovascular disease. It is important
to understand both the cardiovascular anatomy, as well as the pathology of its most
prominent diseases.
1.1. Blood Vessel Anatomy and Physiology
Understanding the anatomical structure and the physiologic mechanisms involved in
blood vessels help to better understand the pathology of diseases that affect blood vessels.
As well, this information can be crucial in the development of solutions to cardiovascular
diseases.
1.1.1. Arteries and Veins
Arteries and veins are the highway system of the human body, transporting
oxygenated red blood cells, nutrients, and chemicals to tissue, as well as transporting deoxygenated red blood cells, waste, and chemicals away from these tissues. Fluid is
always flowing in a loop around the body centering at the heart, the acting pump.
In comparison to veins, arteries have a thicker wall meaning that veins store most of
the blood in the body, around 60%. Veins also contain one-way valves to prevent
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backflow due to low pressure and to fight the forces of gravity. Flow through arteries is
very different from veins. Seen in figure 1, both the pressure and pulse frequency in
arteries are significantly greater than in veins. This succeeds in creating two separate
environments. The arterial environment which, depending on the order of artery, has an
average pressure of around 100 mm Hg ± 20 mm Hg and a frequency of pulse ranging
between 60 bpm and 120 bpm at rest. Comparatively, veins only average around 10 mm
Hg and no pulse frequency.

Figure 1.1 Blood pressure following the order of flow (Waxman, 2010)
1.1.2. Structure of the Vessel Wall
The three basic parts that make up the wall of a blood vessel are the adventitia, media,
and intima. The area where blood flows through is called the lumen. The adventitia is
made up of collagen and elastic tissue. The media consists of smooth muscle cells and
connective tissue. The intima is primarily made up of endothelial cells and a supporting
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layer of tissue. The vessel walls of arteries are much thicker than veins due to the greater
thickness of the media layer and the greater amount of smooth muscle cells in that layer.
1.1.3. Hemodynamics
Blood flow is a result of the pumping action of the heart and is driven by the
differences in pressure in a unidirectional, laminar flow. It often can be simplified as a
fluid flowing through a pipe, where the flow is in a gradient of parallel streamlines,
reaching the maximum velocity in the middle and the minimum at the boundaries, seen in
figure 2.

Figure 1.2. Fluid flow through a pipe with shear forces shown
Flow through a pipe is considered laminar when the Reynold’s number is less than or
equal to 2100. The Reynold’s number can be defined as the inertial forces over the
viscous forces:
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Figure 1.3. Reynold’s number for flow through a straight pipe
The shear stress distribution of the fluid within the pipe is proportional to the velocity
gradient and is defined as:

𝑑𝑢
𝜏 = −𝜇 ( )
𝑑𝑟
This is to say that the blood flow is driven by pressure creating a variation in velocity
that exerts a defined shear stress along the wall of the blood vessel. Steady, laminar flow
shear stress is a mechanical signal to endothelial cells to inhibit coagulation as well
inhibit the migration of leukocytes and the proliferation of smooth muscle cells. (Pollock
et al. 2021; Traub & Berk, 1998)
1.2.Disease Pathology
1.2.1. Peripheral Artery Disease
Atherosclerosis is the narrowing of the arteries that is indicated by the accumulation of
fatty plaques in arteries that obstruct blood flow. During disease progression, plaque
buildups, known as atheromatous plaque or atheroma, may burst, triggering acute
occlusion (Rafieian-Kopaei et al. 2014). Pathogenesis of atherosclerosis is dependent on
a multitude of factors such as the migration of inflammatory response cells such as
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monocytes and platelets, proliferation of smooth muscle cells, cell apoptosis, and the
formation of fibrous structures.
Peripheral artery disease (PAD) is a debilitating, atherosclerotic disease of the lower
limbs that affects between 8 and 12 million people in the U.S. every year (Allison et al.,
2007). Blood flow to the leg is restricted and when blood flow demands are less than the
ability to supply areas of the leg, patients can experience leg cramping and pain.
Intermittent claudication (IC) is a stage of disease progression which is leg cramping and
pain during normal physical activity such as walking and can be alleviated through rest.
IC is associated with quality-of-life concerns, and increased disease progression could
lead to critical limb ischemia (CLI) or acute limb ischemia (ALI). CLI results in
symptoms of limb pain, development of ulcers and sores, skin infections, and gangrene
while ALI results in symptoms of limb pain, tingling sensation in the legs, pallor, and
paralysis. CLI and ALI are both very critical conditions of PAD which are usually treated
surgically (Thukkani and Kinlay, 2015).
1.2.2. Surgical Solutions
The goal of surgical solutions for critical peripheral artery disease is prolongment of
life and limb salvation. As with most surgical problems, the deciding factor of which
solution to choose is based on the case. For example, catheter deployed self-expanding
stents are often used in treatment of infrainguinal arteries. Longer segments of
atherosclerotic lesions, especially in the femoral artery, are treated using bypass graft
surgery, primarily because stents longer than 200 mm have a higher risk of restenosis.
These decisions are made by the surgeon, and it is important to note that peripheral artery
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bypass grafting is still a relevant surgical solution to PAD (Thukkani and Kinlay, 2015;
Slovut and Lipsitz, 2012)
Autologous great saphenous veins are the best conduits for infrainguinal artery bypass
surgery (Thukkani and Kinlay, 2015; El-Sayed, 2012; Macario et al., 2008). The great
saphenous vein continues to have the highest patency rate among grafting options for
PAD and is most often used to bypass the infrapopliteal arteries. This procedure allows
for surgeons to salvage limbs and prolong the survival of patients (El-Sayed, 2012).

Figure 1.4. Various surgical solutions to Peripheral Artery Disease (Luck, 2019)
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1.2.3. Graft Failure
The flaw of bypass grafting is that saphenous vein grafts under arterial loads can
occlude and fail within a period from a few weeks to decades after a patient’s bypass
surgery (Grondin et al., 1984). Other issues may arise because some patients may have
limited availability of viable saphenous vein tissue (Jafarihaghighi et al., 2020). Without
other options, patients may end up having a limb amputation to prolong their lives.
Disease progression starts with migration of smooth muscle cells into the intima and
the development of extracellular fibrosis of the intima in a process called interstitial
hyperplasia (Saucy et al., 2010). This leads to a stiffening of the graft preventing proper
remodeling to occur and eventually leading to the development of thrombosis and
atherosclerotic lesions.
Mechanically, the source of these issues can be traced to disruption of blood flow
including flow reversals and flow separations which occur at anastomotic sites. Without
the high shear, laminar flow of the normal arterial environment, endothelial cells release
factors and express surface molecules that favor the development of atherosclerotic
lesions, thrombosis, and SMC migration (Traub & Berk, 1998).

Figure 1.5. Effects of positive laminar shear stress and low turbulent shear stress on
endothelial cells. Adapted from Traub & Berk, 1998
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Disruption of blood flow is prevalent at the anastomotic sites where blood flow is
disrupted during changes in direction or widening of the lumen (Greenwald 2000). In
end-to-side anastomosis, flow reversal and flow separation can be seen creating areas of
low flow, low shear stress next to areas of high flow, high shear stress. In end-to-end
anastomosis, flow separation is mostly seen at the anastomotic site where the differences
in the lumen sizes creates a widening.

Figure 1.6. End to side and end to end anastomosis and the accompanying flow
disruption points Adapted from Greenwald and Berry, 2000
1.3. Pulsatile Perfusion Bioreactors
Perfusion bioreactors are effective tools for emulation of arterial blood flow,
providing both a steady laminar flow along with a pulsatile pressure and flow pattern
modeled after normal arterial blood flow (Jafarihaghighi et al. 2020).
1.3.1. Usage
Perfusion bioreactors are useful in the emulation of arterial blood flow by providing
both a steady flow between 100 – 450 mL/min as well as the ability to add a pulsatile

8

blood flow between 1 – 2 Hz. Providing both a high laminar shear stress environment
along with cyclic wall deformation is important for mechanical stimulation and
remodeling of saphenous veins in vitro (Tosun & McFetridge 2015, Saucy et al. 2010).
These bioreactors have applications in tissue engineering through in vitro
decellularization of veins and arteries into an extracellular scaffold. These scaffolds can
then be used as a template for different cells to migrate to and grow on (Håkansson et al.
2021).
Other applications include in vitro remodeling of saphenous vein tissue which occurs
during the vessel walls exposure to arterial pressure and flow conditions (Saucy et al.
2010). Often these bioreactors are used in lab experiments which look to show the
biochemical pathways involved in vessel wall remodeling, or in experiments designed to
see the physical changes in the vessel wall over the days remodeling is occurring.
1.3.2. Requirements of Pulsatile Perfusion Bioreactors
Pulsatile perfusion bioreactors (PPBs) come in many different designs that serve
different functions specific to the independent researcher. Still, there are some basic rules
that almost all PPBs must be designed to follow. The most important requirements
include sterility, fluid perfusion and pulse, closed loop system, and the ability to
pressurize the lumen. Other requirements depend on the use of the specific bioreactor.
For tissue culture, the bioreactor should be able to exchange media every few days, as
well, the bioreactor should be able to house inside of a cell culture incubator. Also, the
bioreactor should allow for gas exchange to maintain pH balance.
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CHAPTER TWO
PROJECT APPROACH
2.1. Project Overview
Saphenous vein bypass grafting is currently the most effective surgical option for
peripheral artery disease (PAD) in long lesions. Issues still arise that lead to graft failure,
and, in some patients, failure can occur soon after initial surgery. This puts more people
into the operating room, increasing morbidity and mortality of PAD. The goal of this
project was to design, build, and test a four-channel pulsatile perfusion bioreactor that
emulates pressure and flow profiles while maintaining graft viability for the duration of
two to four weeks. This bioreactor is designed to be incorporated into a custom optical
coherence tomography imaging system.
2.2. Project Justification
Pulsatile perfusion bioreactors come in many different forms for different uses
throughout the world of research. Often these bioreactors are used for experiments
focused on tissue culture and the physical traits associated with vascular remodeling and
the development of intimal hyperplasia. However, there is currently a gap in research,
specifically in live imaging of vascular grafts, that this bioreactor design aims to fill. This
design is adapted to a custom-built optical coherence tomography imaging system as well
as a scanning microscope stage. The combination of the three should work to further the
understanding of the biomechanical forces involved in vascular remodeling and the
development of intimal hyperplasia.
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2.3. Project Aims
The first aim of this project is to design and build a pulsatile perfusion bioreactor that
can accommodate four sample grafts while keeping in mind the requirements and
restrictions of the labs OCT imaging system. The bioreactor should emulate natural,
human pressure wave forms at varying frequencies between 1 Hz and 2 Hz, and varying
pressures between 60 mm Hg and 180 mm Hg. It should also emulate natural, human
flow wave forms ranging from 100 mL/min to 450 mL/min. Both factors need be
monitored in real time and the system should have the ability to easily adjust parameters
such as pressure, pulse rate, and flow. All parts must be able to be sterilized either by
steam sterilization (preferred), or by ethylene oxide (increases cost). The bioreactor
should be consolidated and easily transportable, preferably contained on one plane of
height. The bioreactor should allow for gas exchange and transport of nutrients to the
sample grafts. Media change should be easy to do without risking contamination. The
entire bioreactor system should fit within a cell culture incubator. For this bioreactor,
grafts should be kept in individual cells that allow for the application of drugs to the
ablumen without applying those drugs to the entire system. This will be restricted by the
depth of diffusion of the drugs to prevent mixing into the lumen. Finally, a procedural
protocol should be developed to maximize efficiency in both graft anchoring and
inclusion in the bioreactor loop.
The second aim of this project is to test and validate the bioreactor. The initial
validation is applying and maintaining pressure, as well as creating a pressure waveform
that emulates natural, human pressure waveforms of the femoral artery. The second
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validation is emulating the flow wave form of human femoral arteries using particle
image velocimetry and turbine flow sensors. The final validation is maintaining tissue
viability and sterility of the bioreactor over a two-week period. Both sensor calibration
and the following of proper sterility procedures is crucial for this aim.
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CHAPTER THREE
REVIEW OF PULSATILE PERFUSION BIOREACTORS
Perfusion bioreactors are effective tools for emulation of arterial blood flow,
providing both a steady laminar flow along with a pulsatile pressure and flow pattern
modeled after normal arterial blood flow (Jafarihaghighi et al. 2020). This review will
look at five separate experimental perfusion bioreactors to show the current state of the
technology, and what exactly goes into building a perfusion bioreactor.
3.1. Bioreactor Designs
Dummler et al. used an experimental bioreactor to study the expression of the MMP-2
protein after exposing human saphenous vein grafts (HSVG) to arterial conditions over a
two-week period. Small portions of HSVGs were acquired from 35 patients (average age
71.4 + 7.7 years, 9 females, 26 males) undergoing a coronary artery bypass surgery and
stored on ice until mounted within the perfusion flow system. The perfusion flow system
consisted of a ISMATEC S2 roller pump, a custom vessel chamber, a syringe pump, two
pressure sensors fixed at the inlet and outlet of the vessel chamber, and a PC to control
the pumps and monitor pressure. This was all contained within a Styrofoam insulated
incubator at 37oC. The HSVGs were perfused during various time periods in either
venous conditions (flow = 5 ml/min, pressure = 10 mmHg, n = 12) or arterial conditions
(flow = 50 ml/min, Pressure = 100 mmHg, n = 12). The pressure model used ranged
between 90 and 105 mmHg at 1 Hz. This experiment found that the protein MMP-2 is
upregulated during HSVG exposure to arterial blood flow conditions which has been
linked to the process of remodeling. It also determined that HSVGs supported the arterial
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environment for one week, but after 12 days, the viability of the cells within the graft
began to decrease (Dummler et al. 2011).
Saucy et al. utilized a perfusion bioreactor to study the relationship between the
arterial environment and intimal hyperplasia. Human saphenous veins segments were
acquired from nine patients (average age 67.3 + 0.5 years, 3 females, 6 males)
undergoing peripheral bypass surgery. Parts of each segment were kept as control, half
stored in formal, half frozen in liquid nitrogen. The other segments were perfused in an
experimental perfusion bioreactor that was made up of a peristaltic pump to provide a 4
to 420 ml/min steady flow, a gearing pump to provide a pulsatile flow and pressure
waveform, a vessel chamber made of acrylic, a media cylinder to provide capacitance,
pressure and flow transducers, and a computer to control and monitor flow and pressure.
The media cylinder and the vessel chambers were kept inside an incubator. Vessels were
attached to stainless steel tube fittings using sutures. Perfusion experiments were run for
7 and 14 days. After seven days it was found through histomorphometry that intimal
thickness had increased and had reached its maximum thickness within seven days. Also,
plasminogen activator inhibitor 1 was increased in samples perfused over 7 days. After
14 days the same intimal thickness could be seen as well as a similar amount of
plasminogen activator inhibitor 1. This group successfully accomplished the goal of this
experiment which was to test the viability of their experimental perfusion system for the
remodeling of human saphenous veins (Saucy et al. 2010)
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Figure 3.1 Above shows the increasing intimal thickness from the control segments to
the perfusion segments from 0 days to 14 days. Intima thickness increased over the first 7
days and stayed constant from day 7 to day 14. (Saucy et al. 2010)
Tosun and McFetridge experimented with a perfusion bioreactor to look at the effects
of varying pulse frequencies on vSMC phenotype switching during remodeling. The
pulse rate of an individual was measured throughout a 12-hour period and was used to
model the pulse frequencies of the perfusion bioreactor. A control was set at a constant
pulse frequency of 1.3 Hz. The experimental pulse rate was then used in a 12-hour
varying, 12-hour constant model, and a 24-hour varying model, repeating the 12-hour
sample with no constant frequency. The varying frequencies ranged from less than 1 Hz
to 1.7 Hz. Human vSMCs were sourced from umbilical arteries and seeded onto acellular
scaffolds derived from human umbilical veins. These were perfused under different
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conditions using an experimental perfusion bioreactor. This perfusion bioreactor was
made up of peristaltic pumps (model # EW-68332-06, Cole Parmer, Vernon Hills, IL)
which were linked in series to three vessel chambers. Two separate media chambers were
used for the perfusion of the lumen and the recycling of media within the ablumen. A
computer program was used to increase or decrease the RPM of the peristaltic pumps to
vary the frequency of pulses. Pressure transducers were placed at the outlets of the last
vessel chamber. Variability of pulse frequency showed to have a profound effect on
vSMC seeding and remodeling driving cells to a synthetic state. The graft also showed
increased tensile strength, increased stiffness, and less vasoactivity 24-hour variation of
the pulse frequency showed the highest tensile strength and young’s modulus, with little
to no vasoactivity, representative of development of intimal hyperplasia and resulting
occlusion of the vein graft. Overall, this experiment shows the necessity of varying pulse
frequencies to accurately emulate arterial blood flow conditions in vitro (Tosun and
McFetridge 2015).
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Figure 3.2 Diagram of the perfusion bioreactor used in the Tosun and McFetridge
experiment. Media for the lumen and ablumen were kept separately and recycled
separately. Vessel chambers were linked in series. (Tosun and McFetridge 2015)
Prim et al. developed an experimental perfusion bioreactor to test porcine
replacements of commonly used human bypass graft sources. These included the great
saphenous vein, the internal thoracic artery, and the radial artery. Graft tissues were
harvested from freshly slaughtered pigs (~200 kg; 3 years old) and stored in a modified
Moscona’s saline solution. The perfusion bioreactor consisted of a MasterFlex L/S EasyLoad II roller pump, two custom vessel chambers, a pinch valve, and a pressure
transducer all contained inside of an incubator at 37oC and 5% CO2. All grafts were
perfused using their native environmental conditions as well as a set coronary-like arterial
condition. The coronary perfusion was done at a pressure of 102 mmHg + 8.4 with a
pulse of 1.33 Hz and a flow rate of 0.52 + 0.13 mL/s. After 7 days of perfusion, the
internal thoracic artery had significantly lower intimal and medial cell proliferation
compared to the perfused radial artery and great saphenous vein. Gene expression was
similar in all graft models and the radial artery and saphenous vein seemed to experience
pathological remodeling that was not seen in the internal thoracic artery or the in-situ
graft models. Molecular pathways linked to tissue remodeling were activated as quickly
as 6 hours after introduction to the arterial environment (Prim et al. 2018).
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Figure 3.3 The perfusion bioreactor developed by Prim et al. as well as the length (mm)
of the sample grafts. (Prim et al. 2018)
Hahn et al. utilized a pulsatile perfusion bioreactor to test the effects of biochemical
and biomechanical stimuli on vascular cells over a 7-week perfusion period. In this study,
vascular cells were grafted onto a poly (ethylene glycol) hydrogel scaffold and perfused
at both pediatric heart rates (2 Hz), and adult heart rates (1 Hz), with a min diastolic
pressure of 80 mmHg and a maximum systolic pressure of 120 mmHg. The perfusion
system consisted of a MasterFlex peristaltic pump, a 100 mL glass compliance chamber,
CellMax pulsatile pumps, check valves before and after the pulsatile pump, the vein graft
chamber, a pressure transducer, and a media chamber. The system was housed in a tissue
culture incubator at 5% CO2 and 37oC. Pulsatile flow perfusion had a positive impact on
collagen content as well as the elastic moduli and tensile strength of the grafts when
compared to static culture. As a proof of concept, these results supported their hypothesis
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that a pulsatile flow perfusion system could be used to improve tissue engineered
vascular grafts (Hahn et al. 2006).

Figure 3.4 (a) Bioreactor schematic as well as (b) the pressure versus time waveform,
and (c) pictures of the bioreactor in use. (Hahn et al. 2006)
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Piola et al. developed a pulsatile perfusion bioreactor to study the conditions in which
saphenous vein grafts fail. Their system is designed to cyclically load and unload vein
grafts over defined periods of time. The loads were designed to mimic physiological
venous conditions with constant low pressure (5 mm Hg) as well as arterial conditions
with higher pressure (80 mm Hg – 120 mm Hg). The design was not intended to emulate
flow, but merely to allow for cyclic recirculation of media in the vessel lumen. A roller
pump in conjunction with an electronic pinch valve created the loading, pulsatile loading,
and unloading phases. Experiments were run for validation that looked at pressure versus
volume change within the vessel, tissue viability evaluation using MTT staining,
morphological and immunofluorescence assessments, and morphological measurements.
They found that their bioreactor successfully provided the necessary cyclic loading and
unloading for their desired experiment (Piola et al. 2013).

Figure 3.5 Shows the bioreactor design as well as the pictures for the anchoring of the
SVG procedure. (Piola et al. 2013)
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3.2. Current State of the Art

Reference

Dummler et
al. 2011

Flow Driver

Bioreactor
Type

Tissue Type(s)

Pulsatile
Perfusion
Bioreactor

Human Great
Saphenous Vein

Pressure Parameters (mmHg)
And Pulse Actuator
Ismatec S2 Roller Pump, NA

Venous emulation: 10 (n=12)
Arterial Emulation: 100 (n=12)

Prim et al.
2018

Porcine coronary
Cole-Parmer Masterflex L/S
artery (LAD), internal
Pulsatile
Easy-Load II Roller Pump
thoracic artery (ITA),
Perfusion
Head + Cole-Parmer
radial artery (RA),
Bioreactor
Masterflex L/S Roller Pump,
and great saphenous
NA
vein (GSV)

In Situ: LAD = 102 + 8.4, ITA = 100 +
9.5, RA = 94 + 2.3, GSV = 15 + 1.9,
Coronary: P = 102 + 8.4

Saucy et al.
2010

Pulsatile
Perfusion
Bioreactor

Masterflex L/S Roller Pump,
Ismatec Reglo-Z Gear Pump

Systolic: 80 ± 10 , Diastolic 40 ± 10

Tosun and
McFetridge
2014

Pulsatile
Human Umbilical
Perfusion
Vein (Decellularized)
Bioreactor

Peristaltic Pump, NA

Dual Perfusion Acellular Control:
120/80, Dual perfusion high pressure:
80/120 , Single perfusion low pressure
30-50, Single perfusion high pressure
80/120

Hahn et al
2006

Piola et al.

Human Great
Saphenous Vein

Pulsatile Poly(ethylene glycol)
Masterflex L/S Roller Pump,
Perfusion
Tissue Engineered
100 + 20
CellMax Pulsatile Pumps
Bioreactor
Vascular Grafts
Watson Marlow 323D
Pulsatile
Coranary Artery: Hypotension = 75 +
Human Great
Peristaltic Pump, Solenoid
Perfusion
15 , Normal = 100 + 20 Hypertension =
Saphenous Vein
Pinch Valve (s305-09, SIRAI
Bioreactor
120 + 20, Venous: 5 mmHg
Elettromeccancia)

Table 3.1. Current state of the art of pulsatile perfusion bioreactors.

21

Reference

Flow Parameters

Dummler et al.
2011

Venous emulation: 5
mL/min
Arterial emulation

Prim et al.
2018

Saucy et al.
2010

Frequency
Total Number of
of Pulse
Samples
(Hz)
1 Hz

In Situ: LAD = 0.52 +
In Situ:
0.13 mL/s, ITA = 0.76
LAD =
+ 0.15 mL/s, RA =
1.33, ITA =
0.19 + 0.04 mL/s, GSV
1.22, RA =
= 0.17 + 0.03 mL/s,
1.17, GSV
Coronary: P = 0.52 +
= 1.24
0.13 mL/s

120 ± 15 mL/min

1 Hz

Methodology

Number
of
Channels

Time

24

MTT Staining, Quantitative RT-PCR
Analysis, Zymography for MMP-2 Protein
evaluation

1

1 to 15
days

Each Cultured
Group n = 3

RNA Gene Expression Analysis,
Histological analysis, Protein Expression
Analysis via Staining

2

6 Hours
and 7
Days
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Histological analysis, histomorphological
analysis, immunohistochemical analysis,
gene expression analysis of PAI-1, tPA,
and uPA, PAI-1 ativity analysis

2

14 Days

Histological analysis, SEM, cell density
and metabolic activity, pharmacological
3 (in line)
response using measurements of
contrile force, gene expression vSMC

Tosun and
McFetridge
2014

120 mL/min

Varying

12

Hahn et al
2006

2 mL/s

1 or 2 Hz

NA

0.5,
Coronary Artery: NA,
0.75,1,1.2
Venous: 3 mL/min
Hz
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Piola et al.

Strain analysis, DNA analysis,
Biochemcial anaysis, collagen analysis,
histological analysis
Cyclic loading, stimulation, and
unloading, Pressure-volume
measurements, MTT dead/alive staining,
histological analysis

7 days

3

8 weeks

2

7 days

Table 3.1. (continued) Current state of the art of pulsatile perfusion bioreactors.
Current devices being used in research focus on tissue engineering and remodeling
using genetic, biochemical, or histological analysis. No pulsatile perfusion bioreactors in
the literature were integrated within an OCT imaging system and none of the papers
included OCT imaging as a methodology for studying graft remodeling. There is need for
a pulsatile perfusion bioreactor that can be integrated within an OCT imaging system and
can also be actively imaged during graft perfusion. This should allow our group to study
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the biomechanical forces involved in physiological and pathological remodeling of
vascular grafts.
3.3. Tissue Culture Media

Source

Primary Media

Serum

Additives
2 nM Glutamine

Dummler et al.
2011

DMEM

10% FCS

100 U/ml penicillin
100 µg/ml streptomycin
2% 70-kDa dextran
10,000 U/ml penicillin G

Saucy et al.
2010

RPMI-1640 + Glutamax

30% FCS

10,000 µg/ml streptomycin sulfate
25 mg/ml Amphotericin B
0.5 µg/ml gentamycin

Tosun and
McFetridge
2014

1% L-glutamine
DMEM

10% FBS

1% penicillin streptomycin

1% penicillin streptomycin
Prim et al.
2018

DMEM

10% FBS

Hahn et al.
2006

MEM

10% FBS

Piola et al.
2013

DMEM

10% FBS

1% amphotericin B
1% streptomycin
10 ng/ml TGF-B1
10 µg/mL insulin
50 mM L-ascorbic acid
10 µg/ml ciprofloxacin
100 mU/ml penicillin
100 mg/L streptomycin
0.25 µg/mL fungizone
1% L-Glutamine
1% penicillin streptomycin

Table 3.2. List of media used in reviewed papers.

23

CHAPTER FOUR
DESIGN OF A PULSATILE PERFUSION BIOREACTOR
Pulsatile perfusion bioreactors are designed to provide the necessary amount of
nutrient and gas exchange to cardiovascular tissue, while also modeling the physical
environments of the cardiovascular system (Jafarihaghighi et al. 2020). Small diameter
vascular grafts are important to study, and a bioreactor designed specifically for
saphenous vein grafts would increase the current understanding of grafting strategies and
graft failure.
4.1. Design Needs
A bioreactor is a device that provides a controlled environment that maintains certain
conditions conducive for the development of biological and biochemical processes exvivo. These conditions include pH, temperature, pressure, delivery of nutrients, and the
transport of wastes. Perfusion bioreactors accomplish this through the movement of fluids
over or through cells/tissues (Martin et al. 2004). A pulsatile perfusion bioreactor also
adds the extra element of varying pressure and flow at a given frequency.
Maintaining these conditions is vital for the survival of the cells being studied. Both
pH and temperature can be maintained in a cell culture incubator. Literature shows the
most ideal temperature to be 37 Celsius and the CO2 concentration to be 5% to maintain
pH. Bioreactors must also be designed with gas exchange in mind, either through the use
of silicone tubing or air filters for gas exchange.
Sterility is crucial to maintain during assembly as well as during operation. The
biggest risk of sterility compromise is during the assembly process. Assembly should be

24

conducted under a sterile, laminar flow biological hood using proper PPE and aseptic
techniques. Media should also be sterile and media change should be done underneath the
bio-hood. Finally, the system needs to be sealable to prevent any exposure to the open air,
and place where gas exchange occurs should be done through a sterile air filter.
The design should consider the delivery of nutrients, oxygen, and the transport of
waste to and from the tissue. In the case of a pulsatile perfusion bioreactor, this
accomplished through a media flow loop, powered by a peristaltic pump. This creates a
flow of media through the lumen of the tissue preventing stagnation and a constant
supply of gas and waste exchange. A second actuator mechanism is required to change
the pressure and flow of the loop for pulsatile flow. This can be accomplished using
physical actuators, roller pumps, pneumatic pressure systems, or electronic pinch valves.
Finally, media should be changed every 2 to 3 days to optimize nutrient and gas
exchange.
Fluid pressure and flow measurement is also prioritized in the bioreactor design. This
is both for validation and control of the pressure and flow waveforms. Flow and pressure
measurements should be conducted with the least amount of impact on the experiment.
As well, pressure and flow readings should be instantaneous and easily accessed through
the bioreactors programming. Finally, sensors need to be accurate enough to give reliable
measurements of pressure and flow, and sensors should be calibrated to their
specifications.
Finally, the design should have a defined form which serves to decrease the
complications and fragility of the individual parts. Having four channels, this bioreactor
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has many parts which increase the risk of misplacement and sterility compromise. The
overall form of the design should allow for the best possible ease of assembly and
transport. This form should also consider the internal dimensions of the desired cell
culture incubator. Total cost to build shouldn’t exceed more than $5000.
4.2. Design Phases
When designing anything, it is important to consider and follow a basic design
structure. For designing our bioreactor, we used the structure seen in figure 4.1.

Figure 4.1. Bioreactor design protocol pentagon

26

4.2.1 Research and Review
Extensive literature research of pulsatile perfusion bioreactor designs was conducted
to pinpoint what exactly was needed to build our own. These bioreactors have already
been covered and discussed in section three. From these experimental designs we created
a list of necessary components.

Figure 4.2. List of components gathered from literature review.
The first component necessary to the design is a mechanism for driving flow, most
cases used a peristaltic pump. Our design would use a MasterFlex L/S digital peristaltic
pump.
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The second component, the pulse actuator, had the most variability in form and
function. Some designs used roller pumps (Dummler et al., Saucy et al., Prim et al.), one
used a Berlin Heart (Heise et al. 2003), and other designs used pinch valves (Piola et al.).
Each was different in their approach, but the overall goal was to create a pulsatile
pressure wave form. In our case, our goal was to decrease system noise as much as
possible while also retaining a simplistic design. It was decided to use a pneumatic design
similar to that of the Berlin Heart that could be 3D printed and easily assembled. This
design would use a polydimethylsiloxane (PDMS) membrane as the barrier between the
fluid and the air.
The third component important to the design is the vessel chamber. This varies
depending on the needs of the experiment, but the same requirements hold true for most.
The vessel chamber is where grafts are mounted, often done using surgical sutures. The
design of the chamber should allow for media to completely cover the outside of the graft
and allow for cyclic change of that media. Some designs incorporated perfusion of the
ablumen space as well (Tosun and McFetridge 2015), but for the purposes of this
experiment that won’t be necessary. Some experimenters used sealed containment areas
while other simply covered their containers, the difference seems to be the sterility of the
environment in the cell culture incubators. All vessel chambers were made from clear,
biocompatible materials such as glass, polyethylene terephthalate (PET), polystyrene, or
acrylic. Often these containers were custom made adaptations of common lab containers
used in cell culture. The reproducibility of these containers was thus expensive or time
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consuming. Our design would be a container which would be 3D printed in an
autoclavable material such as polyether ether ketone (PEEK) or a photopolymer resin.
The fourth component is the compliance chamber, which is used to reduce noise as
well as provide the minimum diastolic pressure. Almost all of the experiments used
compliance chambers, and most were either syringe tubes or glass bottles. Syringe tubes
were often used with electronic syringe pumps to adjust the minimum diastolic pressure
during the cycle. For our bioreactor we will use custom glass bottles which will be
pressurized using one-way pressure bulbs from sphygmomanometers.
Finally, at least one check valve is needed to keep flow unidirectional during
perfusion. Most experiments used one way check valves, those that didn’t were using
roller pumps that wouldn’t have any reversal in flow. In this experiment, one-way valves
will be necessary.
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4.2.2. Form Design
With the understanding of what basic components are needed from our literature
review, we were able to create a schematic design to work from, seen in figure 4.3.

Figure 4.3. Schematic of the pulsatile perfusion system using both a peristaltic pump and
pneumatic pressure pump

This design would use the MasterFlex L/S digital peristaltic pump to provide a steady
continuous flow media into a pneumatic pressure pump. This pressure pump would be
controlled with a solenoid valve to provide increased air pressure from the house system.
Media would then flow through a flow straightener and split into four channels into the
bioreactor. Finally, media would flow back into the compliance chamber where the
peristaltic pump would begin the cycle again. Pressure and flow sensors would be placed
before and after the vessels.
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4.2.3. Functional Design
Using the form design, we created a design with detailed parts which can be seen in
figure 4.4.

Figure 4.4. Functional design with detailed parts
This bioreactor would use 3D printed parts for the vessel containment as well as the
pressure box, labeled diaphragm box in figure 4.4. An Arduino mega would be used to
control the solenoid valves as well as collect voltage using analog read to measure the
pressure both in and out of the sample grafts. The vessel chamber would be one solid
piece with four wells for each graft and would be enclosed with a clear acrylic lid.
Vessels would be mounted to metal barbes and held in the center of the wells using 3D
printed scaffolds. Finally, two capacitance bottles would be used before and after the
pressure box to reduce noise. The bottles would be fitted with a glass barb for the outlet,
and custom, 3D printed GL45 caps with barbs for the inlet media and the air pressure.
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4.2.4 Build
Parts were ordered and gathered based on a list of parts. Custom made parts were
created in SolidWorks 3D modeling program and printed using a CreatBot F430 filament
3D printer. As a draft, parts were initially printed in PLA and then final drafts were
printed with PEEK.

Figure 4.5. SolidWorks 3D model of the vessel container system.
Two “keys” would be used along with support pieces to form the graft anchoring
scaffold. The scaffolds would be mounted to the vessel container keeping the vessels
submerged in media.
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Figure 4.6 SolidWorks 3D model of the pressure pump assembly
The pressure pump assembly above is designed to fill with media and is sealed with a
layer of PDMS. The PDMS membrane is spun at around 300 – 400 rpms for 60 seconds
to reach a thickness of 300-400 microns. Norgren solenoid valves control the air pressure
entering and leaving the pressure pump. The pulse frequency is controlled by sending a
signal from the Arduino to the solenoid valves to open or close.
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Figure 4.7. Solenoid Valve from Norgren

Figure 4.8. Circuitry diagram of the solenoid control using an Arduino Uno and 12V
power supply
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Parts were printed and assembled using the functional design diagram as a guide. In
place of sample grafts, 1/8” silicone tubing was used. In place of media we used water to
identify points of failure and receive feedback on this design.
4.2.5 Feedback
After building and testing of the bioreactor, several flaws in the initial design were
identified. These included flaws in the material, as well as the overall form of the design.
Here we will discuss those flaws.
Filament 3D printing was initially chosen due to its accessibility and ease of custom
part building. However, filament 3D printing proved to be too difficult to work with at
this scale. First, this form of 3D printing limits the geometric detail especially in places of
overhangs. Larger details can be scaffolded and still come out without flaw, but smaller
details tend to warp or deform during scaffolding. As well, due to the layering process,
solid parts under pressure leaked through the material. In a system designed to be under
80 mm Hg to 120 mm Hg of pressure this flaw was extremely detrimental. A different
material and printing method would need to be sourced to create the parts we desired.
Another flaw in the initial design was over complication, which was better seen after
building the bioreactor. Having three different tubing sizes (3/8”, 1/4", and 1/8”) was
unnecessary and created to many points where reduction fittings were needed. Also,
many parts of the bioreactor were fragile and would need to be anchored to something to
prevent the tubing from moving or knocking over these parts and breaking them. A new
design that included an anchoring system would need to be developed to prevent
movement of parts as well as allow for ease of transport in and out of the incubator.
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Finally, a sealed vessel chamber with a smaller interior volume would be beneficial
towards the end design. This would improve media changes, transport, and decrease risks
of contamination.
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4.3. Making Improvements
After identifying issues with the original design, a new design can be made in
consideration of these needs. This design can be seen below in figure 4.9.

Figure 4.9. Perfusion system design with anchored parts and simplistic form.
This design is intended for part anchoring to a 12”x18” anodized aluminum
breadboard with 1/4” screw holes spaced 1” apart in a grid pattern. Every loose part
should be anchored to the board to prevent movement during transport. This also keeps
the vessels on the same plane of height as the pressure sensors reducing inaccuracies in
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the pressure readings. External anchoring parts are not shown, but they were created in
SolidWorks and printed using PLA filament 3D printing. This new design also limits
connections outside the incubator to only a few electrical wires.
4.3.1. Choosing a New Material
Considering the drawbacks of filament 3D printing, an improved method to develop
our parts was needed. Resin cured 3D printing used liquid resin and a UV curing process
to make smaller, more detailed parts with limited scaffolding. This technology is often
used in the dental industry to make molds out of a biocompatible resin. Clemson’s
Bioengineering department added a new Bioreactor Development Facility in the summer
of 2021 specifically for the purpose of creating 3D parts using resin-based printing. With
this new resource we were able to develop new parts. The printer used to make these
parts is a Formlabs Form 3B+ resin curing printer.
4.3.2. Pressure Pump

Figure 4.10. New pressure pump assembly printed in BIOE amber dental resin
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The new pressure pump design is similar to the original. The inner geometry is
circular with an entrance and exit for the media. Barbed fittings are now used to ensure a
proper seal for the 1/4” tubing. The air pressure ports are now parallel to the PDMS
membrane to reduce noise caused by the flow of air over the membrane. A base was
created with 1/4” holes for anchoring to an aluminum bread board.
4.3.3. Vessel Chamber

Figure 4.11. Vessel chamber with luer lock connections for reading pressure and
changing media
This is a small vessel chamber design originally created by Dr. Lee Sierad which we
modified to fit our needs. The vessel chamber consists of three parts, the base, the
middle, and the top. The middle part can be seen above in figure 4.11. which contains all
the complexities of the assembly. There are two O-ring tracks, on each side for silicone
O-ring seals. There are 1/8” connectors at each end and block lock connectors for the
placement of small O-rings that lock in vessels without the need for suture ties. Luer
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connectors are on every corner, two of which are connected to the interior of the chamber
for media change, and the other two which are connected to the interior of the tube for
pressure measurements. This allows for the shortest possible distance from the pressure
measurements and the ends of the graft. Six screw holes outline the structure to create a
sealed object. The vessel chamber is clamped to the bread board using L-shaped PLA
clamps.

Figure 4.12. Assembled vessel chamber with a porcine vein and DMEM media
Future experiments that will utilize this bioreactor require a different design for the
vessel chamber, one that accommodates for a water dipping objective. This will be used
during OCT imaging of graft segments. The adjustment being made is only to the top
section of the vessel chamber. In this adjustment, an area is created to allow the objective
to scan in both the x and y direction. As well, a microscope slide can be fixed underneath
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the vessel chamber top acting as the only barrier between the fluid in the chamber and the
microscope objective.

Figure 4.13. Modified vessel chamber top for use with a 24 x 60 mm microscope slide
4.4. Measuring Pressure and Flow
Measuring both pressure and flow in real time is necessary for calibration and
validation of pressure and flow waveforms. Pressure can be measured at multiple points
in our bioreactor. This includes the entrance and exit sites of each sample graft. Flow can
be measured in two different ways, using particle image velocimetry, or using sterile
turbine flow sensors. The advantage to using PIV to measure flow is that it isn’t invasive.
The disadvantage of using PIV is that the measurements wouldn’t be live. A turbine flow
sensor would give us the ability to receive live data and process that data into flow
measurements.

41

4.4.1. Pressure
The bioreactor we designed is a four-channel system, which means that if we
measured pressure at the entrance and exit of each graft, we will have a total of eight
individual sensors. This creates an issue with space, so the sensors that are chosen must
be small, compact, and easy to implement. One of the best ways to accomplish this is to
use board mounted pressure sensors, which are both small, compact, and limited to only a
few wires to connect.
For this bioreactor we chose to use Honeywell SSCDRRN005PDAA5 differential
pressure sensors. These are directly mounted to the breadboard and are powered by the
Arduino Mega prototyping board. An analog voltage signal is sent to the Arduino that
can be converted to a pressure reading using LabView with LINX programming.
Sensors are calibrated using column pressure at known heights and known fluid
density. The relationship between voltage and actual pressure is linear.
4.4.2 Flow
Flow velocity is measured using a Cole-Palmer turbine flow sensor catalog # EW25507-44. The sensor is connected to a data acquisition device (DAQ) and binary data is
used to read flow velocity. The flow sensor is pre-calibrated and specifications for system
calibration are provided by Cole-Palmer.
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4.5. Final Assembly

Figure 4.14. Bioreactor assembly in the cell culture incubator.
Custom 250 mL glass bottles make up the media well and capacitance chambers. The
MasterFlex L/S peristaltic pump transfers fluid between the two bottles and drives flow
in the system. Fluid is drawn and pumped using the custom pressure pump. A solenoid
controls air pressure in the head space which applies a force to the fluid. A one-way valve
ensures that the pressure pump doesn’t reverse flow. Y-splitters divide the flow into four
channels that run through the vein. A pinch clamp creates a closure that increases
resistance and can be used to control end diastolic pressure.

43

4.6. User Interface
NI LabView 2020 is used to show pressure measurements as well as provide an
interface for solenoid opening and closing.

Figure 4.15. Bioreactor control interface
Solenoid control is based on time in milliseconds. In this control format, time open
and time closed are the only two inputs. Multiple inputs can be used to add more details
to the pressure waveform if there is demand for that specificity.
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CHAPTER FIVE
TESTING AND VALIDATION OF A PULSATILE PERFUSION BIOREACTOR
5.1. Pressure Validation
After bioreactor assembly, a validation of pressure function was conducted. This was
done at 60 bpm sampling at a frequency of 20 Hz. End diastolic pressure was equal to 90
mm Hg and end systolic pressure was equal to 115 mm Hg. Solenoid valve opening time
was 750 ms per cycle and closing time was 250 ms per cycle. Input air pressure was
tuned to increase pressure from 90 to 115 mm Hg in the 250 ms timeframe.

Figure 5.1. Pressure waveform at 60 bpm, 5 seconds
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Figure 5.2. Actual pressure waveform (purple, dashed) set at 60 bpm versus simulation
pressure waveform of the femoral artery (orange, solid) at 60 bpm.
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5.2. Compatibility Validation
System compatibility with vein graft segments can be confirmed using simple
experiments based on graft remodeling.
5.2.1. Graft Collection and Preparation
Saphenous vein grafts of sacrificed pigs are collected from Clemson’s Godley-Snell
research facility where we can assure that they are as fresh as possible. The vein is
segmented into four parts 9 cm in length. Before any other manipulation occurs, fresh
samples of 1 cm long rings are excised. These samples are rinsed in Hank’s Balanced Salt
Solution (HBSS) and flash frozen in liquid nitrogen. The rest of the veins are
immediately stored in a solution of HBSS supplemented with 20 U/mL heparin, 1%
penicillin streptomycin, 1% amphotericin B, and 1% gentamycin. After transportation
back to the lab, vein grafts are cut to size, mounted, and secured to the vessel chambers.
Chambers are filled with media consisting of DMEM supplemented with 10% FBS, 1%
penicillin streptomycin, 1% amphotericin B, and 1% L-Glutamine. Time is recorded from
removal to implementation into the bioreactor.
5.2.2. Perfusion Cycle
The vessel chambers are mounted to the bioreactor, and perfusion of the vein grafts
begins by removing all air bubbles within the system. This is done by applying pressure
to the head capacitance bottle and leaving the tail bottle unsealed. Once all air bubbles
can be visually confirmed, steady flow is started using the MasterFlex L/S peristaltic
pump. Flow is set at 150 mL/min. Pressure is tuned to an end diastolic pressure of 80 mm
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Hg with an end systolic pressure of 120 mm Hg, and a pulse rate of 60 bpm. Pressure and
flow are monitored using the LabView user interface. The bioreactor is maintained inside
the cell culture incubator at 37o C and a CO2 concentration of 5%. Media is changed
every 2 days. The perfusion of the vein grafts is done for 7 days. After perfusion is
complete, 1 cm long samples are taken from the middle of the vein grafts and are set in
OCT and frozen for histological analysis at a later time. Another 1 cm sample can also be
taken from each graft to conduct MTT staining.
5.2.3. Histological Analysis
Samples taken before and after perfusion are fixed in OCT and sectioned with a
microtome at a thickness of 5 µm. They are then stained with hematoxylin/eosin. Images
of the stained sections are analyzed using ImageJ to calculate the average intimal
thickness.
5.2.4. MTT Staining
MTT staining can be performed on the extra graft samples to test the viability of the
vein graft segments after and before perfusion. Samples are added to a serum-free
medium with MTT diluted to 0.5 mg/mL They are then incubated at 37o C for one hour.
MTT staining can be used by comparing the change in color. Viable cells will convert the
yellow MTT solution into a purple product. Thus, viable tissue will show up stained
purple and dead tissue will show up stained yellow.
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CHAPTER SIX
CONCLUSIONS
The development of a pulsatile perfusion bioreactor was necessary for the testing of
vascular grafts and grafting techniques. This bioreactor should have the capability to
induce a flow and perfusion profile that emulates that of the arterial environment.
Understanding the conditions that may affect the remodeling and the failure of saphenous
vein grafts will hopefully contribute to the overall understanding of bypass grafting. The
results above show that this completed pulsatile perfusion bioreactor has the following
capabilities.
1. Emulation of physiological pressures, flow, and pulse frequencies which can be
maintained over long periods of time.
2. The ability to provide gas and nutrient exchange in both the lumen and the
ablumen for sample blood vessels.
3. A form that allows for the transport to and from various imaging systems and
special adaptations to allow for optical coherence tomography imaging.
4. Methods of measuring flow and pressure in real time
5. A user interface which can display pressure and flow while allowing for solenoid
opening control.
6. Reproducible custom parts which can be printed at a lower cost to alternative
methods of part development.

49

CHAPTER SEVEN
RECOMMENDATIONS
1. The next step for this bioreactor is to complete validation experiments including
compatibility and flow validation. This falls in line with the need to fine tune
settings of pressure, flow, and pulse to the specific experiment.
2. Vessel chambers are currently only designed to accommodate a singular graft
length and diameter. Adaptations to vessel chamber size are needed to include
grafts of various length. Adapters are needed to include more vessel diameters.
3. Fine tuning and practice of bioreactor implementation into the lab’s optical
coherence tomography imaging system should be conducted.
4. An experiment involving decellularization of saphenous vein tissue should be
performed to test these bioreactors capabilities in recellularization of a tissue
scaffold.
5. A lumped parameter network model including the parameters from the bioreactor
should be created to assist in matching physiological and pathological patient data
to the pressure and flow profiles being created by the bioreactor.
Improvement of this pulsatile perfusion bioreactor should be constant and based on the
experimenter’s experience. This ensures that the bioreactor stays useful to the lab and that
the versatility of the bioreactor increases over time.
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